Detalhe da pesquisa
1.
Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Cancer
; 130(8): 1281-1291, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261521
2.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
3.
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma.
J Vasc Interv Radiol
; 35(5): 722-730.e1, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342221
4.
A dose escalation/expansion study evaluating dose, safety, and efficacy of the novel tyrosine kinase inhibitor surufatinib, which inhibits VEGFR 1, 2, & 3, FGFR 1, and CSF1R, in US patients with neuroendocrine tumors.
Invest New Drugs
; 41(3): 421-430, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074571
5.
Morphology of tumor and nontumor tissue in liver resection specimens for hepatocellular carcinoma following nivolumab therapy.
Mod Pathol
; 34(4): 823-833, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989224
6.
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
Br J Cancer
; 121(3): 218-221, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249394
7.
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
Br J Cancer
; 121(7): 625, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31363170
8.
Chronic thalidomide and chemoembolization for hepatocellular carcinoma.
Oncologist
; 19(12): 1229-30, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361625
9.
Characterization and Management of Adverse Reactions in Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib.
J Adv Pract Oncol
; 14(7): 598-607, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196672
10.
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.
Cancer
; 118(22): 5497-506, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22569804
11.
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 219-229, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065058
12.
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
Oncogene
; 40(1): 140-151, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097857
13.
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
J Clin Oncol
; 38(26): 2960-2970, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716739
14.
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
Cancer Discov
; 9(12): 1696-1707, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31575541
15.
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
PLoS One
; 13(4): e0195149, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29649281
16.
Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancer.
Anticancer Res
; 27(2): 995-1001, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17465233
17.
Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
Hum Gene Ther
; 13(6): 731-43, 2002 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-11936972
18.
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial.
Target Oncol
; 9(2): 145-53, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23660867
19.
Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.
PLoS One
; 7(6): e36979, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22761653
20.
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.
Cancer
; 115(15): 3571-80, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19536893